26 results
Thumbnail

D2.314 - Late Presentation of Cutaneous Chronic Graft Versus Host Disease – A Case Report

Thumbnail

D2.309 - Descriptive Study of Chronic Urticaria Under Treatment with Omalizumab: Our Experience

Thumbnail

D2.310 - Dysregulation of barrier function and distribution of nerve cells in a mouse model of atopic dermatitis

Thumbnail

D2.311 - Real World Web Survey on the Burden of Urticaria

Thumbnail

D2.312 - Impact of metabolic disorders on immune dysregulation in psoriasis and atopic dermatitis

Thumbnail

D2.313 - Importance of non-itchy erythema marginatum as a prodromal symptom of hereditary angioedema attacks

Thumbnail

D2.315 - Clinical features and Progress of Diagnosis and Therapy of Hereditary Angioedema in China: A Systemic Review of Published Cases

Thumbnail

D2.316 - The role of Tumor necrosis factor ligand superfamily member 15 in Atopic dermatitis

Thumbnail

D2.317 - The role of sirtuin 2 (SIRT2) in atopic dermatitis

Thumbnail

D2.318 - Triggers and prodromal indicators of angioedema attacks in hereditary angioedema patients

Thumbnail

D2.319 - Advancing Diagnosis and Management of Hereditary Angioedema in Brazil: Insights from the first 704 patients of a Multicenter Registry

Thumbnail

D2.322 - Quality of life of families with children suffering from chronic urticaria

Thumbnail

D2.323 - Higher neonatal urinary phthalate are associated with the development of infantile atopic dermatitis

Thumbnail

D2.324 - Psychological Burden Associated with Injectable HAE On-Demand Treatments: A Patient and Caregiver Interview Study

Thumbnail

D3.389 - Deep Learning-Based Real-Time Identification of Wheezing in Lung Sounds: Applications in Disease Prediction and Early Intervention

Thumbnail

D3.390 - Rationale and Design for ALPHA-ORBIT: a phase 3 trial of navenibart, a monoclonal antibody inhibitor of plasma kallikrein for participants with hereditary angioedema (HAE)

Thumbnail

D3.391 - Results from the ALPHA-STAR Trial, a Phase 1b/2 Single and Multiple Dose Study to Assess the Safety, Tolerability, Clinical Activity, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Navenibart in Participants with Hereditary Angioedema (HAE)

Thumbnail

D3.392 - What information and education is crucial for people with food allergies?

Thumbnail

D3.393 - Daily life with a peanut allergy, as a young adult- an interview study

Thumbnail

D3.394 - Anxiety Associated with Parenteral On-Demand Treatment for Hereditary Angioedema Attacks in Patients from Italy